Acamprosate Calcium
5 NDCs across 5 manufacturers|5 Generic,0 Brand
Acamprosate Calcium is used to treat alcoholism, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 29, 2004, and the first generic was approved Jul 16, 2013. FDA's Orange Book lists 5 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $6 million on Acamprosate Calcium across 52,000 claims for 17,000 beneficiaries.
Acamprosate Calcium is available as 5 NDCs from 5 manufacturers (5 generic, 0 brand), with NADAC prices from $0.59 to $0.59 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
5G / 0B
Manufacturers
5
competing in market
Price Spread
$0.59 – $0.59
per EA
7d Activity
avg -3.5% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Major Pharmaceuticals manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing ACAMPROSATE CALCIUM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ACAMPROSATE CALC DR 333 MG TAB | $0.5891 per EA | -3.48% |
ACAMPROSATE CALC DR 333 MG TAB | $0.5891 per EA | -3.48% |
ACAMPROSATE CALC DR 333 MG TAB | $0.5891 per EA | -3.48% |
ACAMPROSATE CALC DR 333 MG TAB | $0.5891 per EA | -3.48% |
ACAMPROSATE CALC DR 333 MG TAB | $0.5891 per EA | -3.48% |
Frequently Asked Questions
What is Acamprosate Calcium used to treat?
Acamprosate Calcium is used to treat alcoholism, per the National Library of Medicine's MED-RT classification.
When did Acamprosate Calcium become available as a generic?
FDA approved the first generic Acamprosate Calcium (ANDA) on Jul 16, 2013. The Orange Book currently lists 5 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Acamprosate Calcium?
In 2024, Medicare Part D spent $6 million on Acamprosate Calcium across 52,000 claims for 17,000 beneficiaries.
How many Acamprosate Calcium products are on the market?
The Acamprosate Calcium drug market contains 5 NDCs from 5 manufacturers — 5 generic and 0 brand products.
What is the price range for Acamprosate Calcium?
NADAC reference prices for Acamprosate Calcium range from $0.5891 to $0.5891 per EA.
Which manufacturers make Acamprosate Calcium?
5 manufacturers list Acamprosate Calcium in NADAC. Ranked by number of NDCs, the largest are Major Pharmaceuticals (1), American Health Packaging (1), Zydus Pharmaceuticals (USA) Inc. (1), Glenmark Pharmaceuticals Inc., USA (1), Bionpharma Inc. (1).
How has the price of Acamprosate Calcium changed recently?
Over the past 7 days, 0 Acamprosate Calcium NDCs rose and 5 fell, with a market-wide average change of -3.5%.